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Abstract
Background: Fetal growth restriction (FGR) followed by rapid weight gain during early life has been suggested to be the
initial sequence promoting central adiposity and insulin resistance. However, the link between fetal and early postnatal
growth and the associated anthropometric and metabolic changes have been poorly studied.
Methodology/Principal Findings: Over the first year of post-natal life, changes in body mass index, skinfold thickness and
hormonal concentrations were prospectively monitored in 94 infants in whom the fetal growth velocity had previously been
measured using a repeated standardized procedure of ultrasound fetal measurements. 45 infants, thinner at birth, had
experienced previous FGR (FGR+) regardless of birth weight. Growth pattern in the first four months of life was
characterized by greater change in BMI z-score in FGR+ (+1.26+/21.2 vs +0.58 +/21.17 SD in FGR2) resulting in the
restoration of BMI and of fat mass to values similar to FGR2, independently of caloric intakes. Growth velocity after
4 months was similar and BMI z-score and fat mass remained similar at 12 months of age. At both time-points, fetal growth
velocity was an independent predictor of fat mass in FGR+. At one year, fasting insulin levels were not different but leptin
was significantly higher in the FGR+ (4.43+/21.41 vs 2.63+/21 ng/ml in FGR2).
Conclusion: Early catch-up growth is related to the fetal growth pattern itself, irrespective of birth weight, and is associated
with higher insulin sensitivity and lower leptin levels after birth. Catch-up growth promotes the restoration of body size and
fat stores without detrimental consequences at one year of age on body composition or metabolic profile. The higher leptin
concentration at one year may reflect a positive energy balance in children who previously faced fetal growth restriction.
Citation: Beltrand J, Nicolescu R, Kaguelidou F, Verkauskiene R, Sibony O, et al. (2009) Catch-Up Growth Following Fetal Growth Restriction Promotes Rapid
Restoration of Fat Mass but Without Metabolic Consequences at One Year of Age. PLoS ONE 4(4): e5343. doi:10.1371/journal.pone.0005343
Editor: Thorkild I. A. Sorensen, Institute of Preventive Medicine, Denmark
Received December 26, 2008; Accepted March 31, 2009; Published April 28, 2009
Copyright:  2009 Beltrand et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a grant from the ‘‘Institut National de la Sante ´ et de la Recherche Me ´dicale (INSERM)’’, a grant from the « Programme
Hospitalier de Recherche Clinique » (AOM 06-136, 2006) and from Pfizer Inc. Jacques Beltrand was supported by a fellowship from the ‘‘Institut Appert’’ (France,
2006) and by INSERM (Poste d’accueil, 2007). Ramona Nicolescu received a fellowship from the French ministry of Foreign Affairs (‘‘Programme Charcot’’ 2007).
The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: claire.levy-marchal@inserm.fr
Introduction
A robust regulatory physiologic system has evolved to maintain
relative constancy of weight, an equilibrium broken by modern
lifestyles leading to the development of obesity, type 2 diabetes and
other metabolic disorders. Epidemiological studies have empha-
sized the role of changes in nutritional environment during fetal
life or early infancy. The Dutch famine studies have clearly
illustrated the relation between altered fetal growth induced by
prenatal exposure to famine and increased risk of obesity and
impaired glucose tolerance later in life [1,2]. More recent studies
have suggested that growth trajectory during early infancy,
irrespective of birth weight, is important in determining later
body size, fat mass and body composition [3,4,5]. In several birth
cohorts, growth pattern during the first months of life is a predictor
of obesity and metabolic risk, which effects are observed as early as
in adolescence or childhood [6,7,8,9].
Being born small for gestational age (SGA) is a clinical condition
appropriate for the study of auxological and metabolic conse-
quences of rapid postnatal growth. Indeed, most children born
SGA show a rapid catch-up growth during the first year of life
[10,11]. In most cases but not all, this catch-up follows a phase of
growth restriction during fetal development. This sequence
represents a specific and relevant model to evaluate the
auxological and metabolic consequences of early acceleration of
postnatal growth. Some observations have emphasized that fetal
growth restriction followed by rapid weight gain during early
postnatal life may be a sequence promoting central adiposity,
insulin resistance and ultimately type 2 diabetes and cardiovascu-
lar diseases [12,13]. Fat mass excess and altered insulin sensitivity
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5343are suggested to be early events detectable at one year of age in
children born SGA who experienced weight catch-up [14].
It has been reported that growth velocity at one month of age
was correlated to fetal growth restriction [15]. However, how
much of the catch-up growth relates to the fetal growth
restriction itself during the first year of life and the exact
window when catch-up growth becomes detrimental are not
clearly identified. On the one hand, growth pattern during the
three to four first months of life has been repeatedly reported to
be associated with later clinical or biological markers of
metabolic risk (dyslipidemia, increased blood pressure, abdom-
inal obesity) in birth cohorts of young adults [16,17].On the
other hand, Barker et al. who first reported the association
between birth weight and metabolic diseases, have recently
reopened the debate by suggesting that high-risk subjects for
cardiovascular diseases and diabetes would be the ones small at
birth, thin at two years of age and who rapidly put on weight
thereafter [18]. Before planning nutritional interventions it
remains to be determined whether early catch-up growth is a
phenomenon primarily dependent upon postnatal nutritional
environment or whether it is mostly conditioned by the pattern
of fetal growth. In other words, does this early acceleration of
postnatal growth result from a conflict with postnatal nutrition or
is it a compensatory phenomenon intended to replace infants on
their own physiological growth curves?
The prospective evaluation of fetal growth is generally not
included in the observation of birth cohorts precluding the study of
the exact growth pattern and growth sequence that promote an
increased risk of obesity and/or insulin resistance. In a cohort of
newborns in whom fetal growth velocity had been recorded in a
prospective and standardized manner and using the customized
percentiles, a method that allows a precise evaluation of fetal
growth restriction by identifying newborns who have failed to
reach their genetic potential of growth [19], we have recently
reported that fetal growth restriction by itself, independently from
birth weight, is able to induce changes in body composition with a
lower fat mass and changes in metabolism with a higher insulin
sensitivity [20]. These changes reflect an adaptive process to the
adverse fetal nutritional environment predisposing to rapid
postnatal weight gain in a more favorable postnatal environment.
Such changes were only seen in the newborns that previously
experienced a profound fetal growth restriction but not in
newborns with a regular or sub-regular fetal growth velocity.
The same newborns may be later at high risk of developing of
detrimental auxological and metabolic changes. The aim of the
present study was therefore to relate the pattern of postnatal
growth over the first year of life with fetal growth velocity and to
study the simultaneous changes in body composition and
metabolism.
Methods
Ethics statements
The Ethics Committee Ile-de-France 4 approved the study and
written consent was obtained from both parents for all children.
Study population and inclusion criteria
Results of auxological, anthropometric and metabolic assess-
ments were obtained in a longitudinal study of 94 infants
included at birth in the CASyMIR cohort (figure 1). The
CASyMIR cohort included offspring born to Caucasian parents
recruited during the first or second trimester of pregnancy in
three French maternities (Robert Debre ´a n dX a v i e rB i c h a t
Hospitals in Paris and Edouard Herriot Hospital in Lyon) and
who were considered at risk of delivering small-for-gestational
age babies. The inclusion criteria for the mother were the
following: preexisting hypertension, smoking more than five
cigarettes per day, a previous history of small for gestational age
baby either in a previous pregnancy or among parents, a history
of pregnancy-induced hypertensive disorder, maternal height less
than 152 cm corresponding to -2SD of the mean height for
French women, uterine malformations, abnormal uterine or
umbilical artery Doppler and small fetal size at second trimester
ultrasound examination (abdominal circumference and/or
femoral length at 22 weeks of gestation). All newborns were
evaluated at birth. Newborns presenting with fetal or congenital
diseases that could affect fetal growth were excluded (TORCH
infection, congenital malformation). Very low birth weight and
gestational age below 36 weeks of gestation (WG) or newborns
presenting with a severe neonatal condition were not included in
the post-natal follow-up. Both parents have to give their consent
for day 3 anthropometric evaluation; a second consent was given
for the post-natal follow-up. 269 pregnant women were included
in the study and 235 newborns were evaluated at birth. 127
parents accepted day 3 examination but not postnatal follow-up.
The 108 remaining newborns that fulfilled inclusion criteria were
evaluated at 4 and 9 months. Data for follow-up at one year
were complete in 94 infants.
Figure 1. Study profile.
doi:10.1371/journal.pone.0005343.g001
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The date of conception was determined from the ultrasound
examination at 12 weeks of gestation. Fetal growth was assessed
every 4 weeks by ultrasound from 22 to 36 weeks of gestation by
the same observer for each woman under a standardized
protocol. Details of the procedure were given in previous
publications [20,21]. Estimated fetal weight (EFW) was calcu-
lated using the second Hadlock formula, which includes
abdominal and head circumferences and femur length measure-
ments [22]. The four measurements of EFW and birth weight
were then converted to customized percentiles which were
calculated for each case with a computer program which adjusts
for parity, gender, maternal weight and height and ethnic group
(Gestation related optimal weight (GROW) program, Software
version 5.15. and Centile calculator software v5.12.1. March
2007, www.gestation.net) [19,23]. Fetal growth velocity was
calculated as the change in EFW percentiles from 22 WG until
birth and was expressed as change in percentiles. We previously
reported in the same cohort that a decrease by more than 25
percentiles in fetal growth was associated to metabolic and
anthropometric changes in newborns. Consequently, the same
cut-off limit was kept here to define fetal growth restriction and
infants were divided in 2 groups regardless of birth weight:
newborns with fetal growth restriction or FGR+ group and
newborns with regular fetal growth or FGR2 group.
Post-natal follow-up
All children of the initial cohort born between June 2004 and
February 2007 and who completed 1-year follow-up were included
in the present study. Data concerning these infants were retieved
at birth, at 4 and 12 months of age. No specific dietary
recommendations were given to the parents and time of
introduction of solid food (after 5 months of age) followed the
French pediatric guidelines (http://www.sfpediatrie.com/fr/
groupes-de-specialites/gfhgnp/comite-de-nutrition.html). During
follow-up, infants who developed chronic diseases or who were
taking medications that could interfere with growth or appetite
were excluded.
Measurements
A trained midwife or pediatrician performed the clinical
measurements in all children at birth (in the maternities) and at
4 months and one year of age (at the Clinical Investigation Centre
of Robert Debre ´ Hospital in Paris and in the Neonatal care unit in
Lyon). Weight was measured using an electronic scale to the
nearest 10 grams. Supine length was measured to the nearest
0.5 cm with a standardized length board consisting of a fixed
board for the infant’s head and a movable board allowing feet to
be placed perpendicular to the longitudinal axis of the infant.
Skinfold thickness measurements were recorded at day 3 and at 4
and 12 months of age, on the left side of the body at four different
sites (biceps, triceps, subscapular and suprailliacal), by the same
trained pediatrician dedicated to the study. Two separate
measurement were performed with a skinfold caliper (Harpenden
skinfold caliper, Baty international, England) and the mean was
recorded [24]. Upper arm circumference was measured at day 3
and 4 and 12 months of age. Two separate measurements were
performed at mid arm and the mean recorded. Caloric intakes
were recorded at 4 and 12 months of age using a questionnaire
filled in by the parents with the pediatrician and providing detailed
information on the intakes over the 3 days prior to each visit. If
infants were breastfed at 4 months of age, frequencies and
duration of mealtimes were recorded.
Calculations
Body mass index (BMI=weight/lenght2) at birth, 4 and
12 months of age were calculated as appropriate weight for length
indices as it was independent of length. Weight, length and BMI
were converted into z-scores to adjust for age and sex using the
French references curves [25,26]. Changes in BMI z-score
between birth and 4 months of age and between 4 and 12 months
of age were calculated. Total subcutaneous fat mass was evaluated
using the sum of the four skinfold thicknesses, and central
subcutaneous fat mass using the central to total ratio: (supra-illiac
skinfold+sub-scapular skinfold/sum of skinfold)*100 [24]. Percent-
age of body fat was derived from four skinfold mesurements from
the equations of Brook and Siri [27,28]. Lean body mass was
evaluated using upper arm muscle area that derivates from
skinfolds and upper arm circumference measurements. Upper arm
muscle area (UMA) was obtained by subtracting total upper arm
area (TUA) by upper arm fat area (UFA). TUA was calculated
using the upper arm circumference (AC) with the following
formula: TUA (cm
2)=AC
2/4 x p. UFA was calculated using the
triceps skinfold with the following formula: UFA (cm
2)=AC x
(Triceps skinfold/2) [29]. At birth, small for gestational age (SGA)
was defined as birth weight equal or below the 10
th and
appropriate for gestational age (AGA) as birth weight above the
10
th percentile according to the French reference curves [30].
Insulin sensitivity was assessed using the index QUICKI
(Quantitative insulin sensitivity check index) that was calculated
as: QUICKI=1/(log (fasting insulin)+log (fasting glucose)) [31].
Assays
Hormonal analyses were performed at birth on a mixed venous
and arterial cord blood sample. At 12 months of age, a fasting
venous sample was obtained after an overnight fast. Glucose was
measured immediately whereas samples for hormonal analysis
were quickly centrifuged and serum was separated and stored at
280u until analysis. Serum insulin-like growth factor 1 (IGF-I) was
measured by an immunoradiometric assay (IRMA) kit (IGF-I-
RIACT) from Cis Bio international (Gif-sur-Yvette, France) and
serum IGF-binding protein-3 (IGFBP-3) by an IRMA kit
(ACTIVE IGFBP-3 IRMA) from DSL (Cergy Pontoise, France).
Serum leptin was measured using a specific radioimmunoassay
(Linco research, St Charles, USA). Sensitivity of the assay is
0.4 ng/ml. Intra-and inter- assay coefficients of variation are 5.2%
and 8.7% respectively at 2.3 ng/ml. Serum insulin was measured
by an IRMA kit (BI-INS-IRMA) from Cis Bio international ( Gif-
sur-Yvette, France). Cross-reactivity with proinsulin and derived
metabolites was less than 1%. Assay sensitivity was 3.0 pmol/L.
Serum leptin concentrations were measured using a specific
radioimmunoassay (Linco research, St Charles, USA). Sensitivity
of the assay is 0.4 ng/ml. Intra- and inter- assay coefficients of
variation are 5.2% and 8.7% respectively at 2.3 ng/ml.
Statistical analyses
Comparisons of characteristics between groups were performed
using the Chi-2 test for qualitative variables and the Student’s t test
for quantitative variables. Intragroups comparisons were per-
formed using a non parametric test, the Wilkoxon rank-sum test.
Relationships between continuous variables were assessed by
simple linear regression analysis. We examined the effects of fetal
growth velocity, post natal growth and birth weight on
subcutaneous fat mass measured at 4 and 12 months of age, by
using multivariate linear models. For each multivariate model, we
reported the corresponding coefficient of determination, R
2 which
expresses the proportion of variability in a data set that is
accounted for by the statistical model. All models were statistically
Catch-Up Growth and Metabolism
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heteroscedasticity. Statistical analyses were performed using the
SAS software version 9.1.3 for Windows (SAS statistical package,
SAS institute, Meylan France).
Results
Anthropometric characteristics at birth, 4 months and
12 months of age
Characteristics of the infants at birth, 4 months and 12 months
of age are given in table 1. Gender repartition was not different
between the FGR+ and FGR2 groups. In the first group, mean
change in percentiles of EFW during fetal life was 252.76+/
219.6 percentiles over the second half of pregnancy. Unsurpris-
ingly those FGR+ infants were lighter and thinner at birth as
demonstrated by the lower BMI/birth weight z-scores and the
lower sum of skinfolds at day 3 compared to FGR2 infants. Lean
mass was affected as well as indicated by the lower corrected
UMA.
At 4 months, infants with FGR tended to remain lighter and
shorter as shown by weight and height but there was no difference
in BMI z-score in comparison to the FGR2 infants. During the
four first months of life, change in BMI z-score has been two-fold
greater in the FGR+ group than in the FGR2 group as shown in
figure 2A and 2B). The sum of skinfolds was no longer
statistically different between the two groups indicating that catch-
up growth was related to a restoration of fat mass. However, this
restoration did not result in an excess of fat at 4 months of age
since either sum of skinfold neither the percent of fat (as calculated
by the Brooks equation) was not statistically different between the
two groups (figure 2C and 2D). Fat distribution was not affected
by the accelerated growth as shown by the central to total ratio,
which was not different between FGR+ and FGR2 infants.
Furthermore, catch-up growth was associated with fat-free mass
restoration since UMA was no longer different between the two
groups (figure 2D). The overall proportion of infants breastfed was
low at this age and no difference was observed between the two
groups. In the subgroups of non-breastfed infants, calorie intake
was not different between FGR+ and FGR2 (390+/2113 kcal/
day vs 408+/2152 kcal/day p=0.6 or 60.42+/216.1 kcal/kg day
vs 68.4+/221.7 kcal/kg/day p=0.12).
At 12 months of age, catch-up appears to be completed since
weight, height and BMI (figure 2A and 2B) were similar between
the two groups. At 12 months of age, again there were no
differences either in total subcutaneous fat mass (sum of skinfolds,
figure 2C) or in the calculated percent of fat mass or in the fat
distribution (central to peripheral ratio). Calorie intake remained
similar between the two groups. Between 4 and 12 months of age,
growth velocity was similar in the two groups as reflected by the
change in BMI z-score which was not significantly different
(figure 1 and table 1). Calorie intake remained similar between the
two groups.
Infants in the FGR+ group only showed an important change in
BMI z-score between birth and 12 months (+0.7+/21.1 DS)
whereas BMI z-score did not significantly change in the FGR2
group (20.05+/21.1 DS) and this difference was found to be
statistically significant (p,0.05) (figure 3).
Determinants of sum of skinfold at 4 and 12 months of
age
Table 2 and table 3 shows the determinants of sum of skinfolds,
at 4 and 12 months respectively, in a multivariate analysis in the
FGR+ and FGR2 groups. In the FGR2 group, the sum of
skinfolds at four months, was positively related to birth weight and
Table 1. Characteristics of infants at birth, 4 and 12 months
of age according to fetal growth pattern.
FGR2 FGR+
N= 49 45
Change in percentiles 26.2+/211.6 252.8+/219.6 "
Birth :
Gender (M/F) 18/31 23/22 "
Gestational age 38.9 +/21.62 38.8+/21.73 "
Birth Weight (g) 2913+/2566 2656+/2449
Birth Weigt (DS) 20.76+/21.15 21.3+/20.65 *
Length (cm) 47.9+/22.72 47.16+/22.41 *
Birth Lenght (DS) 20.79+/1.18 21.15+/20.84
BMI (kg/m2) 12.64+/21.24 12.06+/21.02 *
BMI (DS) 20.37+/21.1 20.91+/20.81 *
Sum of skinfold (mm) 16.6+/24.0 14.7+/22.4*
Central to peripheral ratio 52.6+/23.71 51.91+/24.74
Upper arm fat mass area (cm
2) 2.1+/20.7 1.8+/20.5 *
Upper arm muscular area (cm
2) 5.88+/21.5 5.25+/21.1 *
4 Months :
Weight (kg) 6.262+/20.98 5.896+/2846
Weigt (DS) 20.008+/21.3 20.48+/21.1
Height (cm) 61.7+/23.6 60.43+/22.95
Height (DS) 20,12+/21.24 20.58+/1.39
BMI (kg/m2) 16.4+/21.56 16.08+/21.4
BMI (DS) 0.19+/21.1 0.14+/21.03
D IMC 0 to 4 months 0.58+/21.17 1.26+/21.2 *
Breastfed n=(%) 11 (24.4) 6 (14.6)
Sum of skinfold (mm) 31.4+/25.9 30+/26.15
Central to peripheral ratio 48.41+/25.04 48.79+/25.8
Upper arm fat mass area (cm
2) 6.33+/21.8 6.17+/21.6
Upper arm muscular area (cm
2) 8.42+/21.7 8.32+/21.7
Fat Mass % 19.13+/23.4 18.6+/23.6
12 Months :
Weight (kg) 9.271+/21.3 9.147+/21.03
Weigt (DS) 20.26+/21.3 20.46+/20.97
Height (cm) 74.11+/22.6 73.6+/22.5
Height (DS) 0.18+/21.02 20.14+/21.0
BMI (kg/m2) 16.82+/20.4 16.86+/21.2
BMI (DS) 20.4+/21.24 20.37+/20.9
D IMC 4 to 12 months 20.63+/20.24 20.43+/20.8
Caloric intakes (kcal/kg) 92.78+/218 92.95+/223
Sum of skinfold (mm) 28.4+/26.27 28.4+/25.4
Central to peripheral ratio 46.21+/25.71 47.6+/25.13
Upper arm fat mass area (cm
2) 6.79+/21.9 6.67+/21.7
Upper arm muscular area (cm
2)1 1 . 3 +/22.2 11.13+/22.1
Fat Mass % 17.2+/24.09 17.8+/23.3
Data are given as mean +/2 SD.
*p,0.05,
"p,0.01
doi:10.1371/journal.pone.0005343.t001
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model explained 26% of the variance. In the FGR+ group, the
sum of skinfolds at 4 months was also positively related to the same
parameters but was negatively related to changes in EFW
percentiles and these variables explained 52% of the variance in
the data set. The sum of skinfolds at 12 months, was positively
related to birth weight and to change in BMI z-score between
birth and 4 months in FGR2 infants. It was also related to change
in BMI z-score between 4 and 12 months. 35% of the data set
variance was in this case explained by these three parameters.
Finally in the FGR+ group, the sum of skinfolds was negatively
related to fetal growth only and not to the infants’ birth weight.
Fetal growth velocity, together with the early changes in BMI
explained 41% of the variance of sum of skinfolds at 12 months in
this group.
Hormonal changes between birth and 12 months of age
Hormonal data at birth and at 12 months of age are given in
table 4. As previously reported, cord blood Insulin, IGF-1 and
IGFBP3 were lower at birth, in the FGR+ group. At 12 months,
they were no longer different. As previously reported, QUICKI at
birth tended to be higher in the FGR+ group whereas it was
similar in the two groups at 12 months. At birth, cord blood leptin
was lower in the FGR group. Interestingly the venous concentra-
tion was higher at 12 months despite the similar level of fat mass in
the 2 groups. In both group, fat mass and BMI z-score were
correlated with leptin concentration (data not shown). In
multivariate analysis, leptin at 12 months was negatively related
to fetal growth velocity (b=20.004, p=0.05) and positively
related to change in BMI z-score between birth and 4 months
(b=0.12, p=0.008).
Discussion
We report here infants growth pattern of weight, lean and fat
mass in the first year of life in relation with fetal growth pattern but
regardless of birth weight. It is commonly thought that catch-up
growth is a phenomenon only seen in infants born small for
gestational age and a consequence of small birth measurements
[32]. Our data emphasize that catch-up growth is more likely
linked to fetal growth restriction per se than to birth weight,
representing an adaptive and compensatory phenomenon of
rather short duration (first months of life and less than one year)
to compensate for the previous FGR due to unfavorable fetal
environment. Indeed, in our population, fetal growth restriction is
followed by an accelerated growth in order to restore body size, fat
Figure 2. Anthropometric changes during and after catch-up growth. Changes in body mass index (A), body mass index z-score (B), skinfold
thickness sum (C) and upper arm muscle area (D) between birth and one year of age in infants with (black circle) or without fetal growth restriction
(white circle). *p,0.05
doi:10.1371/journal.pone.0005343.g002
Figure 3. Change in BMI related to fetal growth pattern.
Postnatal changes in body mass index between birth and 12 months of
age in infants with (black bars) or without fetal growth restriction (white
bars). *p,0.05
doi:10.1371/journal.pone.0005343.g003
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This accelerated growth took place early in life and is of short
duration as the auxological differences between the two groups of
newborns were no longer present at 4 months of age. Accordingly,
the physiological function of this ‘‘fetal life-induced’’ accelerated
growth seemed to be the correction of body size as it halted when
BMI was restored and growth velocity returned to similar values as
the ones seen in infants with no FGR. However this phenomenon
does not develop here in the detriment of body composition at one
year of age. Accelerated growth is associated with accelerated gain
in both fat and fat-free mass in the first months of life leading to
similar values in both compartments at four months of age in the
two groups.
The fetal programming concept points to the possible
deleterious role played by catch-up growth in body composition
and in metabolic complications. Our results rather highlight that
‘‘catch-up’’ growth during the first year of life is a physiological
and compensatory process that followed a period of growth
deficiency induced by an altered fetal environment and which
aims are to replace the organism on the ‘‘physiological’’ growth
trajectory and to restore body composition. Indeed, in our study
population, subcutaneous fat mass which was decreased at birth in
the FGR+ group was not only linked to the increase in BMI at
both 4 and 12 months of age - as expected- but more interestingly
was negatively linked to fetal growth velocity. The more important
the fetal growth restriction and the lower the fat mass at birth, the
greater the fat mass was in the first year of life. However, this
accelerated growth of the adipose tissue does not induce excessive
fat mass or alteration in its distribution at the age of one year.
Furthermore, the process appears limited in time and there does
not seem to be a prolonged imprinting on fat growth in the first
year of life. When fat stores are restored and growth velocity
returns to normal values, fat accretion becomes similar in both
groups.. Likewise, catch-up growth does not induce detectable
insulin resistance at the end of the first year of life.
Interestingly, the accelerated growth velocity during catch-up
appears here as an intrinsic phenomenon. First, although precise
data on the caloric intakes are lacking for the first weeks of life, we
didn’t find accelerated growth and fat deposition to be associated
Table 2. Determinants of sum of skinfolds at 4 months of age in the two groups of infants.
Dependent variable : Sum of skinfold at 4 months of age
FGR2 FGR+
b 95% CI P value b 95% CI P value
Birthweight (g) 0.003 (0.012;0.001) 0.04 0.004 (20.0002;0.009) 0.06
Change in percentiles of EFW between 22 and birth
(percentiles)
0.05 (20.12;0.22) 0.55 20.12 (20.22;20.035) 0.008
Change in BMI 0–4 months (z- score) 2.79 (0.88;4.5) 0.004 3.28 (1.87;4.7) ,0.001
doi:10.1371/journal.pone.0005343.t002
Table 3. Determinants of sum of skinfolds at 12 months of age in the two groups of infants.
Dependent variable : Sum of skinfold at 12 months of age
FGR2 FGR+
b 95% CI P value b 95% CI P value
Birthweight (g) 0.004 (20.0007;0.008) 0.13 0.004 (20.001;0.007) 0.1
Change in percentiles of EFW between 22 and birth
(percentiles)
20.02 (20.17;20.002) 0.78 20.09 (20.19; 20.015) 0.04
Change in BMI 0–4 months (z- score) 2,53 (0.61;3.59) 0.01 2.10 (0.61;4.43) 0.007
Change in BMI 4–12 months (z- score) 3.39 (0.92;5.86) 0.01 3.36 (0.8;5.97) 0.008
doi:10.1371/journal.pone.0005343.t003
Table 4. Metabolic characteristics of at birth, 4 and
12 months of age according to fetal growth pattern.
FGR2 FGR+
Birth
Glycemia (mmol/l) 3.97+/21.2 4.57+/21.3
Cord Insulin (mUI/l) 4.64+/22.1 2.0+/22.6 "
Cord IGF-1 (ng/ml) 73.62+/235.2 47.26+/236.4 "
Cord IGF-BP3 (mg/ml) 1.25+/20.53 0.8+/20.39 *
Cord Leptin (ng/ml) 8.34+/22.69 4.02+/23.0 "
QUICKI 0.19+/20.03 0.22+/20.03 *
12 Months
Glycemia (mmol/l) 4.6+/20.4 4.66+/20.5
Insulin (mUI/l) 2.28+/21.96 2.38+/22.2
IGF-1 (ng/ml) 82.8+/228.9 80.0+/227.9
IGF-BP3 (mg/ml) 3.09+/20.55 3.15+/20.1
Leptin (ng/ml) 2.63+/21.00 4.43+/21.41 *
QUICKI 0.23+/20.09 0.23+/20.08
Data are given as mean +/2 SD.
*p,0.05,
"p,0.01
doi:10.1371/journal.pone.0005343.t004
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measured in the bottle-fed infants are similar whether previous
FGR or not. Second, growth velocity returned to physiological
values when body composition was restored. Third, the increased
leptin concentration could favor a positive energy balance
promoting this catch-up growth.
The short follow-up of our study and the small number of
children do not allows us to give definitive conclusions on the link
between catch-up growth and later metabolic disease. However,
fetal growth restriction followed by rapid postnatal weight gain has
been clearly pointed as a risk factor of deleterious changes in
insulin sensitivity and body composition. Our data could prompt
to reconsider the timing of such changes and are actually not in
agreement with previous data indicating the early deleterious
effect of catch-up growth. It is important to emphasize that catch-
up growth is not always similar to weight gain. Catch-up growth
implies a weight gain appropriate for height gain. Ong et al first
defined catch-up growth as a gain of weight by more than 0.67 DS
in the first years of life and reported the deleterious consequences
on the later risk of obesity [6]. In the study by Soto et al catch-up
growth in SGA infants was similarly defined and was indeed
associated with increased fasting insulin at one year of age in SGA
infants [14]. However, in the subgroup of SGA infants with such a
catch-up in weight, weight gain was two-fold greater than the one
in height, between birth and one year of age. This greater weight
rather than height gain may suggest that insulin resistance was not
due to a ‘‘physiological’’ catch-up growth but to the excessive gain
in weight and fat. By comparison, weight gain in our cohort was
similar in z-score to height gain (respectively 0.84 and 1.01 DS). In
the study by Veening et al in SGA children, catch-up growth was
defined by height gain from birth to age 7 [33]. Decreased insulin
sensitivity was found only in SGA children that experienced catch-
up with excessive current BMI. Such a distinction between
‘‘developmental’’ catch-up and excessive weight gain could
furthermore explain some discordant results on the relationship
between birth measurements and the metabolic risk. A recent
study reported the determinants of insulin sensitivity in young
adults born either AGA or SGA [34]. The only independent
determinant of insulin sensitivity was fat gain from birth rather
than birth size itself or catch-up growth (the definition of which
was based on height). Only one group has followed anthropomet-
ric and metabolic changes in SGA and AGA children from 2 to
6 years of age [13,35]. At inclusion, catch-up growth was
completed in SGA children and BMI or percent fat were similar
to AGA children. Yet, fat gain was greater in SGA children
between 2 and 6 years of age and was associated with changes in
insulin sensitivity. If BMI was similar in both groups at 4 years of
age, it was greater in SGA children at 6. These results indicate that
after the period of early catch-up, growth infants enter a second
critical phase of auxological changes, from 2 years onward, where
weight gain and changes in BMI would be associated to negative
changes in fat mass and in insulin sensitivity.
With consideration to these previous studies, our results prompt
us to revise the natural history of fetal programming and insulin
resistance. Hence, a deleterious fetal environment and more
specifically fetal growth restriction induces adaptive changes in the
fetal metabolism in order to adjust to a predicted poor postnatal
environment. Therefore, these changes ensure not only immediate
fetal survival but also postnatal survival. Fetal growth restriction
compromises growth of nutrient storage organs such as adipose
tissue and this is compensated by adaptive metabolic changes such
as greater insulin sensitivity to favour energy efficiency and
utilization of alternate source of substrates. These changes would
result to a thin newborn whose metabolism would be programmed
to storage and efficient energy utilization. Indeed, metabolic
changes, as suggested by the developmental mismatch theory [36],
are in ‘‘conflict’’ with an adequate postnatal environment. This
‘‘conflict’’ ultimately results to the well-described catch-up growth.
Further, our results highlight that such catch-up growth does not
strictly always overlap with excessive postnatal weight gain
especially when it follows a fetal growth restriction. In this
particular situation, catch-up growth seems to be an endogenous
and physiological process dedicated to the restoration of body size
and composition without negative consequences on insulin
metabolism. Later in childhood, the higher leptin secretion
observed at one year of age could play an important role in the
future metabolic and auxological deleterious changes.
Leptin levels has been widely accepted as a marker of fat mass,
and leptin receptors are expressed in several tissues including
fetal cartilage, bone lung kidney or hypothalamus suggesting that
leptin may exert its biological functions in the fetus and/or early
life. Cord leptin has been recently reported to be a predictor of
weight gain over the first six months of age and of anthropo-
metric outcomes at 3 years of life [37]. In healthy children, the
role of leptin is first to regulate energy homeostasis by
modulating energy intake and expenditure. It also regulates
several nueroendocrine axes including the growth hormone-IGF
axis [38,39]. The lower neonatal concentration of leptin, already
reported in SGA newborns [40,41,42] could impair the
development of hypothalamic pathways. Recent studies in
rodents have illustrated the plasticity of arcuate nucleus
projections in the neonatal period and have described a role
for leptin as being a neurotrophic signal for the development of
hypothalamic circuits [43,44,45]. Finally, although no clear
effects on calorie intakes was evidenced during the first year of
life, the reduced neonatal concentration of leptin may have long-
term consequences on food intake, nutrient storage and body
weight control. On the other hand, the higher leptin concentra-
tion observed here as early as one year of age and consistently
reported in SGA individuals [40,46] could contribute to a
positive energy balance and later fat mass accretion, which in
turn will induce insulin resistance leading to a vicious cycle of
escalating metabolic diseases. The short duration of our follow-
up is clearly a restriction to such a conclusion; however, results
from previous human or animal studies are concordant with this
idea. A recent work on an animal model of nutritional induced
fetal growth restriction has pointed the crucial role played by
leptin signalling modulation in the puppets. In this compromised
infant rats, leptin administration shifted the developmental
programme from a metabolically unhealthy to a healthy one
[47].
In conclusion, early catch-up growth following fetal growth
restriction promotes restoration of fat stores and does not induce
unfavourable changes either in body composition or in insulin
sensitivity at one year of age. However, changes in leptin secretion
and/or sensitivity occurring in the first year of life could be an
important metabolic marker of fetal programming. Perturbations
in perinatal nutrition that alter leptin sensivity could have lifelong
consequences for control of body weight, fat mass and insulin
sensitivity, but the real relevance of our observation remains to be
further demonstrated. Interventions in early life in order to
promote weight gain by increasing caloric or protein intake have
shown that modulation of infant growth during first months of life
could lead to deleterious changes in blood pressure, altered flow-
mediated endothelial dilatation [48,49,50]. Our results support
that interventions in the first months of life may not be appropriate
with respect to the metabolic risk during such a window of plastic
development of numerous organs.
Catch-Up Growth and Metabolism
PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5343Acknowledgments
The authors are grateful to the nursing staff of the Clinical Investigation
Centre (CIC 9202) of Robert Debre ´ hospital and to Bernadette
Reygrobellet. We acknowledge the skilful technical assistance of Aurore
Foureau, Saphia Faked and Yaya Barry.
Author Contributions
Conceived and designed the experiments: JB CLM. Performed the
experiments: JB RN RV OC. Analyzed the data: JB CLM. Contributed
reagents/materials/analysis tools: OS DC. Wrote the paper: JB FK CLM.
Conducted the postnatal follow-up: RN OC. Provided statistical expertise:
FK. Conducted prenatal follow-up: RV. Organized the prenatal follow-up:
OS. Conducted the hormonal analysis: DC. Conducted the study: CLM.
References
1. Ravelli GP, Stein ZA, Susser MW (1976) Obesity in young men after famine
exposure in utero and early infancy. N Engl J Med 295: 349–353.
2. Roseboom T, de Rooij S, Painter R (2006) The Dutch famine and its long-term
consequences for adult health. Early Hum Dev 82: 485–491.
3. Botton J, Heude B, Maccario J, Ducimetiere P, Charles MA (2008) Postnatal
weight and height growth velocities at different ages between birth and 5 y and
body composition in adolescent boys and girls. Am J Clin Nutr 87: 1760–1768.
4. Chomtho S, Wells JC, Williams JE, Davies PS, Lucas A, et al. (2008) Infant
growth and later body composition: evidence from the 4-component model.
Am J Clin Nutr 87: 1776–1784.
5. Yliharsila H, Kajantie E, Osmond C, Forsen T, Barker DJ, et al. (2008) Body
mass index during childhood and adult body composition in men and women
aged 56–70 y. Am J Clin Nutr 87: 1769–1775.
6. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB (2000) Association
between postnatal catch-up growth and obesity in childhood: prospective cohort
study. Bmj 320: 967–971.
7. Ekelund U, Ong K, Linne Y, Neovius M, Brage S, et al. (2006) Upward weight
percentile crossing in infancy and early childhood independently predicts fat
mass in young adults: the Stockholm Weight Development Study (SWEDES).
Am J Clin Nutr 83: 324–330.
8. Stettler N, Zemel BS, Kumanyika S, Stallings VA (2002) Infant weight gain and
childhood overweight status in a multicenter, cohort study. Pediatrics 109:
194–199.
9. Stettler N, Kumanyika SK, Katz SH, Zemel BS, Stallings VA (2003) Rapid
weight gain during infancy and obesity in young adulthood in a cohort of
African Americans. Am J Clin Nutr 77: 1374–1378.
10. Colle E, Schiff D, Andrew G, Bauer CB, Fitzhardinge P (1976) Insulin responses
during catch-up growth of infants who were small for gestational age. Pediatrics
57: 363–371.
11. Ezzahir N, Alberti C, Deghmoun S, Zaccaria I, Czernichow P, et al. (2005)
Time course of catch-up in adiposity influences adult anthropometry in
individuals who were born small for gestational age. Pediatr Res 58: 243–247.
12. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, et al. (2005)
Dynamic change in adiposity from fetal to postnatal life is involved in the
metabolic syndrome associated with reduced fetal growth. Diabetologia 48:
849–855.
13. Ibanez L, Suarez L, Lopez-Bermejo A, Diaz M, Valls C, et al. (2008) Early
development of visceral fat excess after spontaneous catch-up growth in children
with low birth weight. J Clin Endocrinol Metab 93: 925–928.
14. Soto N, Bazaes RA, Pena V, Salazar T, Avila A, et al. (2003) Insulin sensitivity
and secretion are related to catch-up growth in small-for-gestational-age infants
at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 88:
3645–3650.
15. Larsen T, Greisen G, Petersen S (1997) Intrauterine growth correlation to
postnatal growth–influence of risk factors and complications in pregnancy. Early
Hum Dev 47: 157–165.
16. Ekelund U, Ong KK, Linne Y, Neovius M, Brage S, et al. (2007) Association of
weight gain in infancy and early childhood with metabolic risk in young adults.
J Clin Endocrinol Metab 92: 98–103.
17. Law CM, Shiell AW, Newsome CA, Syddall HE, Shinebourne EA, et al. (2002)
Fetal, infant, and childhood growth and adult blood pressure: a longitudinal
study from birth to 22 years of age. Circulation 105: 1088–1092.
18. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG (2005) Trajectories
of growth among children who have coronary events as adults. N Engl J Med
353: 1802–1809.
19. Gardosi J, Mongelli M, Wilcox M, Chang A (1995) An adjustable fetal weight
standard. Ultrasound Obstet Gynecol 6: 168–174.
20. Beltrand J, Verkauskiene R, Nicolescu R, Sibony O, Gaucherand P, et al. (2008)
Adaptive changes in neonatal hormonal and metabolic profiles induced by fetal
growth restriction. J Clin Endocrinol Metab 93: 4027–4032.
21. Beltrand J, Alison M, Nicolescu R, Verkauskiene R, Deghmoun S, et al. (2008)
Bone mineral content at birth is determined both by birth weight and fetal
growth pattern. Pediatr Res 64: 86–90.
22. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK (1985) Estimation of
fetal weight with the use of head, body, and femur measurements–a prospective
study. Am J Obstet Gynecol 151: 333–337.
23. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM (1992) Customised
antenatal growth charts. Lancet 339: 283–287.
24. Rodriguez G, Samper MP, Olivares JL, Ventura P, Moreno LA, et al. (2005)
Skinfold measurements at birth: sex and anthropometric influence. Arch Dis
Child Fetal Neonatal Ed 90: F273–275.
25. Rolland-CacheraMF,ColeTJ,SempeM,Tichet J,RossignolC,etal. (1991) Body
Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 45: 13–21.
26. Sempe M (1977) Study of growth from birth to 18 months. Arch Fr Pediatr 34:
687–688.
27. Brook CG (1971) Determination of body composition of children from skinfold
measurements. Arch Dis Child 46: 182–184.
28. Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:
239–280.
29. Rolland-Cachera MF, Brambilla P, Manzoni P, Akrout M, Sironi S, et al. (1997)
Body composition assessed on the basis of arm circumference and triceps
skinfold thickness: a new index validated in children by magnetic resonance
imaging. Am J Clin Nutr 65: 1709–1713.
30. Leroy B, Lefort F (1971) The weight and size of newborn infants at birth. Rev Fr
Gynecol Obstet 66: 391–396.
31. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000)
Quantitative insulin sensitivity check index: a simple, accurate method for
assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402–2410.
32. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, De Muinck
Keizer-Schrama SM, et al. (1995) Children born small for gestational age: do
they catch up? Pediatr Res 38: 267–271.
33. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA (2002)
Glucose tolerance, insulin sensitivity, and insulin secretion in children born small
for gestational age. J Clin Endocrinol Metab 87: 4657–4661.
34. Leunissen RW, Oosterbeek P, Hol LK, Hellingman AA, Stijnen T, et al. (2008)
Fat Mass Accumulation during Childhood Determines Insulin Sensitivity in
Early Adulthood. J Clin Endocrinol Metab 93: 445–451.
35. Ibanez L, Ong K, Dunger DB, de Zegher F (2006) Early development of
adiposity and insulin resistance after catch-up weight gain in small-for-
gestational-age children. J Clin Endocrinol Metab 91: 2153–2158.
36. Gluckman PD, Hanson MA (2004) Living with the past: evolution, development,
and patterns of disease. Science 305: 1733–1736.
37. Mantzoros CS, Rifas-Shiman SL, Williams CJ, Fargnoli JL, Kelesidis T, et al.
(2009) Cord blood leptin and adiponectin as predictors of adiposity in children at
3 years of age: a prospective cohort study. Pediatrics 123: 682–689.
38. Brennan AM, Mantzoros CS (2006) Drug Insight: the role of leptin in human
physiology and pathophysiology–emerging clinical applications. Nat Clin Pract
Endocrinol Metab 2: 318–327.
39. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS (2003) The role of
falling leptin levels in the neuroendocrine and metabolic adaptation to short-
term starvation in healthy men. J Clin Invest 111: 1409–1421.
40. Jaquet D, Leger J, Tabone MD, Czernichow P, Levy-Marchal C (1999) High
serum leptin concentrations during catch-up growth of children born with
intrauterine growth retardation. J Clin Endocrinol Metab 84: 1949–1953.
41. Bazaes RA, Salazar TE, Pittaluga E, Pena V, Alegria A, et al. (2003) Glucose
and lipid metabolism in small for gestational age infants at 48 hours of age.
Pediatrics 111: 804–809.
42. Schubring C, Siebler T, Kratzsch J, Englaro P, Blum WF, et al. (1999) Leptin
serum concentrations in healthy neonates within the first week of life: relation to
insulin and growth hormone levels, skinfold thickness, body mass index and
weight. Clin Endocrinol (Oxf) 51: 199–204.
43. Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of leptin on
hypothalamic neurons that regulate feeding. Science 304: 108–110.
44. Bouret SG, Simerly RB (2007) Development of Leptin-Sensitive Circuits.
J Neuroendocrinol 19: 575–582.
45. Ikenasio-Thorpe BA, Breier BH, Vickers MH, Fraser M (2007) Prenatal
influences on susceptibility to diet-induced obesity are mediated by altered
neuroendocrine gene expression. J Endocrinol 193: 31–37.
46. Martinez-Aguayo A, Capurro T, Pena V, Iniguez G, Hernandez MI, et al.
(2007) Comparison of leptin levels, body composition and insulin sensitivity and
secretion by OGTT in healthy, early pubertal girls born at either appropriate- or
small-for-gestational age. Clin Endocrinol (Oxf) 67: 526–532.
47. Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, et al.
(2005) Neonatal leptin treatment reverses developmental programming.
Endocrinology 146: 4211–4216.
48. Singhal A, Cole TJ, Fewtrell M, Deanfield J, Lucas A (2004) Is slower early growth
beneficial for long-term cardiovascular health? Circulation 109: 1108–1113.
49. Singhal A, Cole TJ, Fewtrell M, Kennedy K, Stephenson T, et al. (2007)
Promotion of faster weight gain in infants born small for gestational age: is there
an adverse effect on later blood pressure? Circulation 115: 213–220.
50. Singhal A, Fewtrell M, Cole TJ, Lucas A (2003) Low nutrient intake and early
growth for later insulin resistance in adolescents born preterm. Lancet 361:
1089–1097.
Catch-Up Growth and Metabolism
PLoS ONE | www.plosone.org 8 April 2009 | Volume 4 | Issue 4 | e5343